TREPS: Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of Psychotherapy

Sponsor
Hannover Medical School (Other)
Overall Status
Unknown status
CT.gov ID
NCT01391897
Collaborator
(none)
300
1
20
15

Study Details

Study Description

Brief Summary

This reported observational clinical study aims at identifying epigenetic markers in a sample of patients undergoing high dose inpatient psychotherapy suffering from a variety of psychiatric/psychosomatic diseases such as somatoform disorders, posttraumatic stress disorder (PTSD), depression, anxiety disorders and eating disorders.

The exact epigenetic markers that will be traced are yet to define.

The investigators believe that

  1. Epigenetic patterns found in the group of psychiatric patients show differences from healthy controls

  2. Different diagnosis show differences in epigenetic patterns as well

  3. Epigenetic patterns correlate to the severity of the psychosocial disorder as measured in interviews or psychometric ratings

  4. Epigenetic patterns can change under inpatient high dose psychotherapy

  5. Changes correlate to clinical psychometric variables.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: psychotherapy

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Study Start Date :
Jan 1, 2011
Anticipated Primary Completion Date :
Jan 1, 2012
Anticipated Study Completion Date :
Sep 1, 2012

Arms and Interventions

Arm Intervention/Treatment
in- and out-patient psychotherapy patients

All included patients are highly selected in- and outpatients in a department of psychosomatic medicine (Germany) undergoing high dose psychotherapy (e.g. group therapy, creative therapy, cbt and psychodynamic psychotherapy).

Behavioral: psychotherapy
"multimodal complex psychotherapy"
Other Names:
  • all patients in the department are primarily included. There are no parallel groups.
  • Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 65 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • informed consent given by the patient

      • adulthood to 65 years

      • stabel physical health

      • at least fluent in German language (as it is a group-therapy)

      Exclusion Criteria:
      • psychiatric disorder such as substance addiction, psychosis, schizophrenia.

      • insufficient understanding of the terms and conditions of the study

      • insufficient emotional stability to fill out the psychometric forms required for the study.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 HannoverMS Hannover Lower Saxony Germany 30625

      Sponsors and Collaborators

      • Hannover Medical School

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT01391897
      Other Study ID Numbers:
      • MHH-EK-5689
      First Posted:
      Jul 12, 2011
      Last Update Posted:
      Jul 12, 2011
      Last Verified:
      Jun 1, 2011

      Study Results

      No Results Posted as of Jul 12, 2011